EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 50 filers reported holding EDITAS MEDICINE INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,455 | -5.2% | 443 | 0.0% | 0.00% | – |
| Q2 2023 | $3,645 | +13.5% | 443 | 0.0% | 0.00% | – |
| Q1 2023 | $3,211 | -18.3% | 443 | 0.0% | 0.00% | – |
| Q4 2022 | $3,929 | -21.4% | 443 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | 0.0% | 443 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -37.5% | 443 | 0.0% | 0.00% | – |
| Q1 2022 | $8,000 | -11.1% | 443 | +29.2% | 0.00% | – |
| Q4 2021 | $9,000 | 0.0% | 343 | +41.2% | 0.00% | – |
| Q3 2021 | $9,000 | -18.2% | 243 | +21.5% | 0.00% | – |
| Q2 2021 | $11,000 | +37.5% | 200 | 0.0% | 0.00% | – |
| Q1 2021 | $8,000 | -42.9% | 200 | 0.0% | 0.00% | – |
| Q4 2020 | $14,000 | +180.0% | 200 | 0.0% | 0.00% | – |
| Q3 2020 | $5,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2020 | $5,000 | +66.7% | 200 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -82.4% | 200 | -60.0% | 0.00% | – |
| Q1 2016 | $17,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. VI, L.L.C. | 4,656,173 | $160,824,000 | 96.46% |
| Alphabet Inc. | 256,410 | $8,856,000 | 3.65% |
| Casdin Capital, LLC | 85,470 | $2,952,000 | 3.39% |
| Wildcat Capital Management, LLC | 247,768 | $8,558,000 | 2.98% |
| Omega Fund Management, LLC | 105,007 | $3,627,000 | 2.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $59,043,000 | 2.51% |
| EcoR1 Capital, LLC | 87,921 | $3,037,000 | 1.06% |
| Foresite Capital Management III, LLC | 14,500 | $501,000 | 0.39% |
| VIKING GLOBAL INVESTORS LP | 2,135,523 | $73,761,000 | 0.32% |
| Schonfeld Strategic Advisors LLC | 9,726 | $336,000 | 0.14% |